Will The DSCSA Cause Drug Shortages After January 1?

Dr. Connie T. Jung, Acting Associate Director for Policy & Communications, Office of Drug Security, Integrity and Recalls, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, spoke last week at the 2014 Healthcare Distribution Management Association (HDMA) Traceability Seminar in Arlington, VA. The presentation was similar to those given

Looking for Serialization & Tracing Insights?

To get full access to this and other great RXTRACE_LOGO_Trans_250x94 essays, you need to
either Login, or upgrade your current subscription!
 Unlimited access is just a few clicks away!
To learn why RXTRACE_LOGO_Trans_250x94 is such a great value, click here.









2 thoughts on “Will The DSCSA Cause Drug Shortages After January 1?”

  1. Dirk,
    You have stated well the conundrum that Wholesaler Distributors face in the new year even when they are prepared for the new law. This situation may be compounded, in a negative way, by the timing of the requirement on the FDA to publish the Standards for TI / TH / and TS.

    Best Regards,
    Geoff

  2. I wonder how a manufacturer could develop a single data exchange system for all trading partners. Installing a third party software for the trading partners is not a solution. If this is then the wholesalers would end up with many such systems and this a complete CHAOS. Can anyone explain how this is possible with just 20 odd days to go.How can anyone

Comments are closed.